{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:13:30Z","timestamp":1782274410862,"version":"3.54.5"},"reference-count":82,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jaip.2020.03.017","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T02:05:29Z","timestamp":1585879529000},"page":"2565-2574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Eosinophils in COPD\u2014Current Concepts and Clinical Implications"],"prefix":"10.1016","volume":"8","author":[{"given":"Katarzyna","family":"Mycroft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal","family":"Krenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"G\u00f3rska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.03.017_bib1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/all.13760","article-title":"Inflammatory endotypes in COPD","volume":"74","author":"Barnes","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.03.017_bib2","doi-asserted-by":"crossref","first-page":"1802058","DOI":"10.1183\/13993003.02058-2018","article-title":"Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report","volume":"53","author":"McDonald","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib3","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jaip.2019.04.022","article-title":"Asthma-COPD overlap\u2014a discordance between patient populations defined by different diagnostic criteria","volume":"7","author":"Barczyk","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.03.017_bib4","doi-asserted-by":"crossref","first-page":"1700853","DOI":"10.1183\/13993003.00853-2017","article-title":"Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort","volume":"50","author":"Kim","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1183\/09031936.06.00072105","article-title":"Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment","volume":"27","author":"Leigh","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib6","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2147\/COPD.S100338","article-title":"Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD","volume":"11","author":"Negewo","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2020.03.017_bib7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/15412555.2019.1675150","article-title":"Relationship between blood and induced sputum eosinophils, bronchial hyperresponsiveness and reversibility of airway obstruction in mild-to-moderate chronic obstructive pulmonary disease","volume":"16","author":"Proboszcz","year":"2019","journal-title":"COPD"},{"key":"10.1016\/j.jaip.2020.03.017_bib8","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.00146306","article-title":"Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial","volume":"29","author":"Siva","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/2040622315609251","article-title":"Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease","volume":"7","author":"George","year":"2016","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jaip.2020.03.017_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.20452\/pamw.3299","article-title":"Comparative study of periostin expression in different respiratory samples in patients with asthma and chronic obstructive pulmonary disease","volume":"126","author":"Gorska","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.jaip.2020.03.017_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1183\/09031936.00.15110900","article-title":"Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD","volume":"15","author":"Rutgers","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1183\/20734735.042912","article-title":"Induced sputum analysis: step by step","volume":"9","author":"Weiszhar","year":"2013","journal-title":"Breathe"},{"key":"10.1016\/j.jaip.2020.03.017_bib13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","article-title":"An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease","volume":"185","author":"Meyer","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib14","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/resp.13312","article-title":"Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD","volume":"23","author":"Hartjes","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2020.03.017_bib15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0091-6749(89)90120-6","article-title":"Heterogeneity of human eosinophils","volume":"83","author":"Fukuda","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.017_bib16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0091-6749(88)90912-8","article-title":"The presence of hypodense eosinophils and diminished chemiluminescence response in asthma","volume":"81","author":"Shult","year":"1988","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.017_bib17","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1172\/JCI85664","article-title":"Lung-resident eosinophils represent a distinct regulatory eosinophil subset","volume":"126","author":"Mesnil","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2020.03.017_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/15412555.2017.1416074","article-title":"Comparative study of IL-33 and IL-6 levels in different respiratory samples in mild-to-moderate asthma and COPD","volume":"15","author":"Gorska","year":"2018","journal-title":"COPD"},{"key":"10.1016\/j.jaip.2020.03.017_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2466-14-112","article-title":"COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils","volume":"14","author":"Eltboli","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4168\/aair.2010.2.2.87","article-title":"Eosinophil survival and apoptosis in health and disease","volume":"2","author":"Park","year":"2010","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2020.03.017_bib21","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1182\/blood-2014-10-607788","article-title":"Eosinophil-specific deletion of I\u03baB\u03b1 in mice reveals a critical role of NF-\u03baB-induced Bcl-xL for inhibition of apoptosis","volume":"125","author":"Schwartz","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.03.017_bib22","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.4049\/jimmunol.181.4.2790","article-title":"Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease","volume":"181","author":"Ying","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2020.03.017_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12931-018-0807-y","article-title":"The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD","volume":"19","author":"Tworek","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2020.03.017_bib24","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/all.12655","article-title":"Differential activation of airway eosinophils induces IL-13-mediated allergic Th2 pulmonary responses in mice","volume":"70","author":"Jacobsen","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.03.017_bib25","doi-asserted-by":"crossref","first-page":"1801291","DOI":"10.1183\/13993003.01291-2018","article-title":"Eosinophil-derived IL-13 promotes emphysema","volume":"53","author":"Doyle","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib26","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1172\/JCI10458","article-title":"Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema","volume":"106","author":"Zheng","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2020.03.017_bib27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2011.12.996","article-title":"Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity","volume":"129","author":"Chaudhuri","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.017_bib28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S2213-2600(17)30432-0","article-title":"Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort","volume":"5","author":"Hastie","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.arbres.2017.01.014","article-title":"Post-bronchodilator reversibility of FEV1 and eosinophilic airway inflammation in COPD","volume":"53","author":"Chou","year":"2017","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.jaip.2020.03.017_bib30","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1440-1843.2008.01380.x","article-title":"Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related","volume":"13","author":"Reid","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2020.03.017_bib31","first-page":"261","article-title":"Eosinophilic airway inflammation in chronic obstructive pulmonary disease and asthma","volume":"59","author":"G\u00f3rska","year":"2008","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.jaip.2020.03.017_bib32","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.2147\/COPD.S142466","article-title":"Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap","volume":"12","author":"Gao","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2020.03.017_bib33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1164\/rccm.200401-112OC","article-title":"Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease","volume":"170","author":"Lapperre","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12931-017-0570-5","article-title":"Blood and sputum eosinophils in COPD: relationship with bacterial load","volume":"18","author":"Kolsum","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2020.03.017_bib36","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1164\/rccm.201708-1684LE","article-title":"Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease","volume":"197","author":"Turato","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12931-019-1130-y","article-title":"Evaluation of exacerbations and blood eosinophils in UK and US COPD populations","volume":"20","author":"Vogelmeier","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2020.03.017_bib38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(18)30327-8","volume":"6","author":"Ferguson","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib39","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.2147\/COPD.S179425","article-title":"Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids","volume":"13","author":"Siddiqui","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2020.03.017_bib40","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1164\/rccm.201701-0193OC","article-title":"Blood eosinophils and response to maintenance chronic obstructive pulmonary disease treatment: data from the FLAME trial","volume":"195","author":"Roche","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib42","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jaci.2018.04.010","article-title":"Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease","volume":"141","author":"Yun","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.017_bib43","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1183\/13993003.01370-2015","article-title":"Blood eosinophils as a marker of response to inhaled corticosteroids in COPD","volume":"47","author":"Barnes","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/thoraxjnl-2015-207021","article-title":"Blood eosinophils and inhaled corticosteroid\/long-acting \u03b2-2 agonist efficacy in COPD","volume":"71","author":"Pavord","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2020.03.017_bib45","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nri.2017.95","article-title":"Functions of tissue-resident eosinophils","volume":"17","author":"Weller","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2020.03.017_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.rmed.2016.01.013","article-title":"Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort","volume":"112","author":"DiSantostefano","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib47","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.anai.2016.08.010","article-title":"Variability of blood eosinophil count as an asthma biomarker","volume":"117","author":"Mathur","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.03.017_bib48","doi-asserted-by":"crossref","first-page":"1701162","DOI":"10.1183\/13993003.01162-2017","article-title":"Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD","volume":"50","author":"Casanova","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib49","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1183\/09031936.00162414","article-title":"Eosinophilic inflammation in COPD: prevalence and clinical characteristics","volume":"44","author":"Singh","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib50","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.chest.2019.04.012","article-title":"Stability of the blood eosinophilic phenotype in stable and exacerbated chronic obstructive pulmonary disease","volume":"156","author":"Schumann","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2020.03.017_bib51","doi-asserted-by":"crossref","first-page":"1800427","DOI":"10.1183\/13993003.00427-2018","article-title":"The reproducibility of COPD blood eosinophil counts","volume":"52","author":"Southworth","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib52","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201701-0009LE","article-title":"Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts","volume":"195","author":"Oshagbemi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib53","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/15412555.2017.1313827","article-title":"Stability of blood eosinophil count in patients with COPD in the UK Clinical Practice Research Datalink","volume":"14","author":"Landis","year":"2017","journal-title":"COPD"},{"key":"10.1016\/j.jaip.2020.03.017_bib54","doi-asserted-by":"crossref","first-page":"e000151","DOI":"10.1136\/bmjresp-2016-000151","article-title":"Effect of inhaled corticosteroids on blood eosinophil count in steroid-naive patients with COPD","volume":"3","author":"Kreindler","year":"2016","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jaip.2020.03.017_bib55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/15412555.2016.1260539","article-title":"Eosinophilic and neutrophilic airway inflammation in the phenotyping of mild-to-moderate asthma and chronic obstructive pulmonary disease","volume":"14","author":"Gorska","year":"2017","journal-title":"COPD"},{"key":"10.1016\/j.jaip.2020.03.017_bib56","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1183\/09031936.00012415","article-title":"Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes","volume":"46","author":"Westerhof","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib57","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jaci.2014.09.034","article-title":"High blood eosinophil counts predict sputum eosinophilia in patients with severe asthma","volume":"135","author":"Fowler","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.017_bib58","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib59","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.201502-0235LE","article-title":"Blood eosinophils: a biomarker of response to extrafine beclomethasone\/formoterol in chronic obstructive pulmonary disease","volume":"192","author":"Siddiqui","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib60","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0140-6736(18)30206-X","article-title":"Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.03.017_bib61","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1164\/rccm.201803-0405OC","article-title":"Long-term triple therapy de-escalation to indacaterol\/glycopyrronium in patients with chronic obstructive pulmonary disease (SUNSET): a randomized, double-blind, triple-dummy clinical trial","volume":"198","author":"Chapman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib62","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib63","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","article-title":"Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen General Population Study","volume":"193","author":"Vedel-Krogh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib64","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.chest.2019.02.406","article-title":"Low and high blood eosinophil counts as biomarkers in hospitalised acute exacerbations of chronic obstructive pulmonary disease","volume":"156","author":"MacDonald","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2020.03.017_bib65","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12931-018-0840-x","article-title":"Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease","volume":"19","author":"Shin","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2020.03.017_bib66","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","article-title":"Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial","volume":"4","author":"Watz","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib67","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib68","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.chest.2018.12.016","article-title":"Adding a LAMA to ICS\/LABA therapy: a meta-analysis of triple combination therapy in COPD","volume":"155","author":"Calzetta","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2020.03.017_bib69","doi-asserted-by":"crossref","first-page":"1801586","DOI":"10.1183\/13993003.01586-2018","article-title":"Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis","volume":"52","author":"Cazzola","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib70","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.201612-2525LE","article-title":"Eosinophilia, frequent exacerbations, and steroid response in chronic obstructive pulmonary disease","volume":"196","author":"Calverley","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib71","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2147\/COPD.S129787","article-title":"Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD","volume":"12","author":"Zysman","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaip.2020.03.017_bib72","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S2213-2600(13)70040-7","article-title":"Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials","volume":"1","author":"Dransfield","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib73","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/thoraxjnl-2012-202872","article-title":"Inhaled corticosteroids in COPD and the risk of serious pneumonia","volume":"68","author":"Suissa","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2020.03.017_bib74","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chest.2017.05.020","article-title":"Precision medicine urgency: the case of inhaled corticosteroids in COPD","volume":"152","author":"Suissa","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2020.03.017_bib75","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-2600(18)30368-0","article-title":"Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study","volume":"6","author":"Suissa","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib76","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1056\/NEJMoa1516385","article-title":"Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD","volume":"374","author":"Wedzicha","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib77","doi-asserted-by":"crossref","first-page":"1800120","DOI":"10.1183\/13993003.00120-2018","article-title":"Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD","volume":"51","author":"Vedel-Krogh","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib78","doi-asserted-by":"crossref","first-page":"1800981","DOI":"10.1183\/13993003.00981-2018","article-title":"Blood eosinophils in COPD and the future risk of pneumonia","volume":"52","author":"Ernst","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.017_bib79","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1164\/rccm.201409-1654PP","article-title":"Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease: a double effect of inhaled corticosteroids?","volume":"191","author":"Festic","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib80","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","article-title":"Mepolizumab for eosinophilic chronic obstructive pulmonary disease","volume":"377","author":"Pavord","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib81","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S2213-2600(14)70187-0","article-title":"Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study","volume":"2","author":"Brightling","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib82","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S2213-2600(19)30338-8","article-title":"Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies","volume":"8","author":"Criner","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2020.03.017_bib83","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jaip.2019.01.036","article-title":"T2 Biologics for chronic obstructive pulmonary disease","volume":"7","author":"Yousuf","year":"2019","journal-title":"J.\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820302609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820302609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:26:49Z","timestamp":1761974809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820302609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":82,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2213219820302609"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.03.017","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophils in COPD\u2014Current Concepts and Clinical Implications","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}